SWOT Analysis for Samrat Pharmachem Ltd. - Opportunity

Add SWOT widget to your site/app

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Strong Performer, Under Radar Stocks (DVM)

Profit making Companies with High ROCE and Low PE

Undervalued Growth Stocks

Value Stocks, Under Radar (DVM)

Stocks seeing month price declines, good financial durability, and newly affordable valuations (subscription)

Company with high TTM EPS Growth

PEG lower than Industry PEG

Companies with rising net profit margins - quarterly as well as TTM basis

Affordable Stocks - Stocks with Good Trendlyne Valuation Score

Growth in Net Profit with increasing Profit Margin (QoQ)

Company with Low Debt

Increasing profits every quarter for the past 4 quarters

Book Value per share Improving for last 2 years

Company with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Top Gainers

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Oversold by Money Flow Index (MFI)

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Declining Revenue every quarter for the past 3 quarters

Annual net profit declining for last 2 years

Near 52 Week Low

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Highest fall from 52 Week High

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

Companies with improving valuation scores after share price falls

Promoters increasing shareholding QoQ

Bullish or Bearish Candlestick Strength - Indices

Decline in Quarterly Net Profit with falling Profit Margin (YoY)